Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
23.75
-0.45 (-1.86%)
At close: Nov 17, 2026

SHA:688443 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
315.61,5382,0352,89249.2814.15
Trading Asset Securities
1,552681.23412.5827.71237.36427.11
Cash & Short-Term Investments
1,8682,2192,4482,920286.64441.25
Cash Growth
-19.35%-9.36%-16.16%918.65%-35.04%684.19%
Accounts Receivable
344.5721.0812.01---
Other Receivables
3.150.061.380-1.53
Receivables
347.7221.1413.380-1.53
Inventory
166.0496.1250.1555.4556.3333.66
Other Current Assets
90.86107.08110.5956.5656.0352.76
Total Current Assets
2,4732,4432,6223,032399529.2
Property, Plant & Equipment
478.58482.76441.55487.82487.75327.83
Other Intangible Assets
45.5642.6943.5943.5445.0845.92
Long-Term Deferred Charges
19.1120.1725.1627.9225.5123.51
Other Long-Term Assets
5.694.4113.263.464.7776.36
Total Assets
3,0222,9933,1463,595962.111,003

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
94.0895.4367.0683.0467.8446.61
Accrued Expenses
67.2987.363.0337.7429.7124.29
Short-Term Debt
100.06--0.63--
Current Portion of Long-Term Debt
29.03158.8126.24-5.30.9
Current Portion of Leases
-11.0712.1310.077.646.51
Current Unearned Revenue
141.08114.52----
Other Current Liabilities
19.885.595.825.415.877.7
Total Current Liabilities
452.63472.72174.29136.87126.3786.01
Long-Term Debt
793.66884.82786.13608.48738.59535.55
Long-Term Leases
4.257.9812.6321.8230.3728.65
Long-Term Unearned Revenue
38.5943.0446.6243.237.6935.55
Other Long-Term Liabilities
124.29----5.08
Total Liabilities
1,4131,4091,020810.36933.03690.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
366.68366.68366.68366.68275275
Additional Paid-In Capital
4,2224,1924,1924,038573.29279.82
Retained Earnings
-2,960-2,953-2,418-1,621-819.21-242.84
Treasury Stock
-20.3-20.3-14.67---
Shareholders' Equity
1,6081,5852,1262,78429.08311.98
Total Liabilities & Equity
3,0222,9933,1463,595962.111,003

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
9271,063837.13640.99781.91571.6
Net Cash (Debt)
940.961,1561,6112,279-495.27-130.35
Net Cash Growth
-25.84%-28.22%-29.31%---
Net Cash Per Share
2.833.154.387.11-1.80-0.47
Filing Date Shares Outstanding
366.68366.68366.68366.68275275
Total Common Shares Outstanding
366.68366.68366.68366.68275275
Working Capital
2,0201,9712,4482,895272.63443.19
Book Value Per Share
4.394.325.807.590.111.13
Tangible Book Value
1,5631,5422,0822,741-15.99266.06
Tangible Book Value Per Share
4.264.215.687.47-0.060.97
Buildings
-115.11115.03114.98105.8999.77
Machinery
-529.02516.53457.63302.65261.93
Construction In Progress
-94.416.7452.18164.8218.27